AlzeCure Pharma (ALZCUR) — Financial Flexibility Index
AlzeCure Pharma (ALZCUR) has a Financial Flexibility Index of -0.48x as of September 2025. Free cash flow of Skr-7.62 Million (operating CF Skr-7.62 Million minus capex Skr0.00) represents 0% of total liabilities (Skr15.93 Million). Check strategic asset allocation of AlzeCure Pharma to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AlzeCure Pharma Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for AlzeCure Pharma across 8 annual periods. See ALZCUR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for AlzeCure Pharma (2017–2024)
Year-by-year free cash flow to debt coverage for AlzeCure Pharma. For the full company profile including market capitalisation, see ALZCUR market cap.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.24x | Skr-35.00 Million | Skr-35.12 Million | Skr8.25 Million | ▼ -1241.7% |
| 2023 | 0.37x | Skr3.06 Million | Skr3.06 Million | Skr8.23 Million | ▲ +103.9% |
| 2022 | -9.65x | Skr-99.91 Million | Skr-99.91 Million | Skr10.35 Million | ▼ -73.2% |
| 2021 | -5.57x | Skr-70.58 Million | Skr-70.64 Million | Skr12.67 Million | ▲ +42.8% |
| 2020 | -9.73x | Skr-68.84 Million | Skr-69.51 Million | Skr7.07 Million | ▲ +5.3% |
| 2019 | -10.28x | Skr-48.82 Million | Skr-50.28 Million | Skr4.75 Million | ▼ -32.4% |
| 2018 | -7.76x | Skr-35.81 Million | Skr-36.27 Million | Skr4.61 Million | ▼ -294.8% |
| 2017 | -1.97x | Skr-8.15 Million | Skr-8.42 Million | Skr4.15 Million | — |